Table 1.
Clinical Characteristics
| Patient | Gender | Age | Laterality | Thyroid treatment |
Time dx to surgery |
Steroids Y/N |
Smoking Y/N |
CON | CAS |
|---|---|---|---|---|---|---|---|---|---|
| C1 | F | 69 | N/A | N/A | N/A | N | Unk | N/A | N/A |
| C2 | M | 54 | N/A | N/A | N/A | N | Unk | N/A | N/A |
| C3 | M | 41 | N/A | N/A | N/A | N | Unk | N/A | N/A |
| C4 | M | 61 | N/A | N/A | N/A | N | Unk | N/A | N/A |
| G1 | F | 59 | OU | RAI, methimazole, thyroidectomy | 13 mo | Y | N | Y | 7 |
| G2 | M | 49 | OU | Tapazole | 10 mo | Y | N | Y | 5 |
| G3 | F | 58 | OS | Methimazole | 9 mo | Y | Y | Y | 7 |
| G4 | M | 48 | OD | Methimazole | 10 mo | N | Y | N | 2 |
| G5 | F | 67 | OU | RAI | 36 mo | N | Y | N | 1 |
| G6 | F | 35 | OU | Methimazole, propranolol | 13 mo | N | N | N | 1 |
| G7 | F | 65 | OU | none | 3 mo | Y | N | Y | 5 |
| G8 | F | 70 | OU | Methimazole | 4 mo | Y | N | N | 2 |
| G9 | F | 64 | OS | Methimazole | 3 mo | N | N | Y | 7 |
| G10 | M | 49 | OU | Tapazole | 20 mo | Y | N | Y | 5 |
| G11 | F | 61 | OU | RAI | 2 mo | Y | Y | Y | 5 |
| G12 | F | 66 | OU | Thyroidectomy | 15 mo | N | N | N | 5 |
| G13 | F | 33 | OU | RAI | 84 mo | N | N | N | 2 |
| G14 | M | 37 | OS | Thyroidectomy | 96 mo | N | N | N | 3 |
| G15 | F | 77 | OU | Methimazole | 24 mo | Y | N | N | 2 |
CAS=clinical activity score; CON=compressive optic neuropathy; F=Female; M=male; mo=month; N=no; N/A=not applicable; OD=right eye; OS=left eye; OU=both eyes; RAI=radioactive iodine; Unk=unknown; Y=yes